We are live on ! Find out more
ACA

Acorn Capital Advisors Portfolio holdings

AUM $352M
1-Year Est. Return 299.18%
This Fund
S&P 500
This Quarter Est. Return
+48.52%
1 Year Est. Return
+299.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
+$44.1M
Cap. Flow
-$11.1M
Cap. Flow %
-5.64%
Top 10 Hldgs %
87.67%
Holding
22
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
JSPR icon
Jasper Therapeutics
JSPR
+$4.19M
2
CRDF icon
Cardiff Oncology
CRDF
+$1.53M
3
XFOR icon
X4 Pharmaceuticals
XFOR
+$308K

Top Sells

Rank Stock Value
1
YMAB
Y-mAbs Therapeutics
YMAB
+$15.4M
2
MURA
Mural Oncology
MURA
+$1.61M
3
YARW
Yarrow Bioscience, Inc. Common Stock
YARW
+$98.1K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$6.28B
$45.6M 23.14%
1,131,501
– –
URGN icon
2
UroGen Pharma
URGN
$1.86B
$25.1M 12.76%
1,259,749
– –
PBYI icon
3
Puma Biotechnology
PBYI
$404M
$21.9M 11.14%
4,131,299
– –
TRVI icon
4
Trevi Therapeutics
TRVI
$2.59B
$19.6M 9.96%
2,144,844
– –
TERN
5
DELISTED
Terns Pharmaceuticals
TERN
$14.8M 7.52%
1,971,264
– –
CADL icon
6
Candel Therapeutics
CADL
$733M
$13.2M 6.68%
2,580,517
– –
BCAX
7
Bicara Therapeutics
BCAX
$1.78B
$10.2M 5.16%
643,382
– –
OKUR
8
OnKure Therapeutics
OKUR
$154M
$7.81M 3.96%
2,839,674
– –
TARA icon
9
Protara Therapeutics
TARA
$220M
$7.62M 3.87%
1,752,115
– –
VSTM icon
10
Verastem
VSTM
$510M
$6.88M 3.49%
779,498
– –
HELP
11
Cybin Inc
HELP
$485M
$4.31M 2.19%
734,394
– –
CRDF icon
12
Cardiff Oncology
CRDF
$66.5M
$4.04M 2.05%
1,962,084
+553,317
+39% +$1.53M
AURA icon
13
Aura Biosciences
AURA
$725M
$3.68M 1.87%
595,744
– –
BCAB icon
14
BioAtla
BCAB
$5.46M
$3.34M 1.69%
96,702
– –
JSPR icon
15
Jasper Therapeutics
JSPR
$21M
$3.29M 1.67%
+1,382,640
New +$4.19M
WHWK
16
Whitehawk Therapeutics
WHWK
$190M
$2.16M 1.1%
1,139,363
– –
QTTB icon
17
Q32 Bio
QTTB
$466M
$1.59M 0.81%
803,425
– –
XFOR icon
18
X4 Pharmaceuticals
XFOR
$375M
$935K 0.47%
273,349
+119,619
+78% +$308K
ACRV icon
19
Acrivon Therapeutics
ACRV
$64.2M
$733K 0.37%
405,237
– –
YARW
20
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$199K 0.1%
11,731
-3,000
-20% -$98.1K
MURA
21
DELISTED
Mural Oncology
MURA
– –
-653,779
Closed -$1.61M
YMAB
22
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-3,418,995
Closed -$15.4M

Similar funds

PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
HIA
HTG Investment Advisors New Canaan, Connecticut $352M AUM 17.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
FWM
ForthRight Wealth Management Alpharetta, Georgia $353M AUM 12.98% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Acorn Capital Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Acorn Capital Advisors held 22 positions worth $197M, up 29% from $153M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Acorn Capital Advisors withdrew a net $11.1M in Q3 2025, closing 2 positions and reducing 1 holding. Its most notable exit was Y-mAbs Therapeutics, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Acorn Capital Advisors opened a new position in Jasper Therapeutics worth $3.29M.

  • Acorn Capital Advisors's largest Q3 2025 buy was Jasper Therapeutics: 1,382,640 shares worth $3.29M.
  • Acorn Capital Advisors added most to Cardiff Oncology in Q3 2025, an estimated $1.53M increase.
  • Acorn Capital Advisors's biggest Q3 2025 reduction was Yarrow Bioscience, Inc. Common Stock, cutting an estimated $98.1K.
  • Acorn Capital Advisors fully exited Y-mAbs Therapeutics in Q3 2025, selling an estimated $15.4M.
  • Acorn Capital Advisors's ten largest holdings make up 88% of its $197M portfolio in Q3 2025.
  • Acorn Capital Advisors opened 1 new position and closed 2 in Q3 2025.
  • Acorn Capital Advisors's portfolio value rose 29% quarter-over-quarter to $197M.

Based on Acorn Capital Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.